Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Ophthalmology Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... capita consumption, the market was $6.6 and in terms of global GDP, the market was 0.05%. Ophthalmology drugs was the ninth largest segment within the market accounting for 3.4% preceded and followed by gastrointestinal drugs ... Read More
-
Anti-Infective Drugs Global Market Briefing 2022: Ukraine-Russia War Impact
... consumption, the market was $28.7 and in terms of global GDP, the market was 0.25%. Anti-infective drugs was the largest segment within the market accounting for 15.1% followed by oncology drugs at 13.7% and central ... Read More
-
Global Tinnitus Drug Market Size study, by Treatment Type (Anti-Depressants, Anti- Anxiety, Anti-histamines, Anti-convulsant), Distribution Channel (Retail Pharmacies, Drug stores, E-commerce), and Regional Forecasts 2022-2028
... million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.50% over the forecast period 2022-2028. Tinnitus is defined as a condition in which a person intentionally hears noises ... Read More
-
Global Pregabalin Market 2022-2026
... the pregabalin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis of the current global ... Read More
-
GIVINOSTAT Emerging Drug Insight and Market Forecast – 2032
... GIVINOSTAT for Polycythemia Vera in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
IMCIVREE (Setmelanotide), Drug Insight and Market Forecast – 2032
... IMCIVREE (Setmelanotide) for Obesity in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
The U.S. Autism Treatment Centers Market
... provided by therapists. There are waiting lists, significant untapped demand, and private equity investors are backing new ventures. Franchises are emerging. The incidence of autism among American children has soared from 1 in 150 in ... Read More
-
Dominican Republic specific Pollen Allergies Market
... data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation Dominican Republic Specific Pollen Allergies Market, By Drug Type (Antihistamines, Decongestants, Corticosteroids, ... Read More
-
BOMEDEMSTAT Emerging Drug Insight and Market Forecast – 2032
... BOMEDEMSTAT for Polycythemia Vera in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
SAXENDA (Liraglutide), Drug Insight and Market Forecast – 2032
... SAXENDA (Liraglutide) for Obesity in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
XENICAL (Orlistat), Drug Insight and Market Forecast – 2032
... XENICAL (Orlistat) for Obesity in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
BESREMi Drug Insight and Market Forecast – 2032
... Polycythemia Vera in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed description of ... Read More
-
JAKAFI Drug Insight and Market Forecast – 2032
... Polycythemia Vera in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed description of ... Read More
-
QSYMIA (Phentermine– topiramate), Drug Insight and Market Forecast – 2032
... detailed picture of the QSYMIA (Phentermine– topiramate) for Obesity in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this ... Read More
-
XOLAIR Marketed Drug Insight and Market Forecast − 2032
... of the XOLAIR for Chronic Spontaneous Urticaria in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
Sapablursen Emerging Drug Insight and Market Forecast – 2032
... Sapablursen for Polycythemia Vera in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
Tirzepatide, Emerging Drug Insight and Market Forecast – 2032
... for Obesity in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed description of ... Read More
-
Rusfertide Emerging Drug Insight and Market Forecast – 2032
... Rusfertide for Polycythemia Vera in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast – 2032
... CONTRAVE (Naltrexon-Bupropion) for Obesity in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
WEGOVY (Semaglutide), Drug Insight and Market Forecast – 2032
... WEGOVY (Semaglutide) for Obesity in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
EXSERVAN Drug Insight and Market Forecast – 2032
... EXSERVAN for Amyotrophic Lateral Sclerosis in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
Mexico Republic specific Pollen Allergies Market
... for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation Mexico Specific Pollen Allergies Market, By Drug Type (Antihistamines, Decongestants, Corticosteroids, Anticholinergics and ... Read More
-
VRAYLAR Emerging Drug Insight and Market Forecast – 2032
... of the VRAYLAR for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
LOU064 Emerging Drug Insight and Market Forecast − 2032
... of the LOU064 for Chronic Spontaneous Urticaria in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
Women Health Market Share, Size, Trends, Industry Analysis Report, By Type (Surgical, Contraceptive, Critical Care, Labor & Delivery, Diagnostic, Others), By Application; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030
... Health Market size is expected to reach USD 58.10 billion by 2030, according to a new study by Polaris Market Research. The report “Women Health Market Share, Size, Trends, Industry Analysis Report, By Type (Surgical, ... Read More
Research Assistance
